No Data
Anavex Life Sciences Corp. (NASDAQ:AVXL): Is Breakeven Near?
Express News | HC Wainwright & Co. Reiterates Buy on Anavex Life Sciences, Maintains $40 Price Target
Anavex Life Sciences: Buy Rating Driven by Promising Blarcamesine Developments and Market Expansion
Anavex Life Sciences Shares Are Trading Higher After the Company Announced New Data From the Phase IIb/III Study Showing That Blarcamesine, Once Daily Orally, Demonstrates Pre-specified Clinical Efficacy Through Upstream SIGMAR1 Activation.
12 Health Care Stocks Moving In Thursday's Intraday Session
JonesTrading Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $15
No Data
No Data
104128755 : $15 is possible, how many shares are u holding on to?
Rhiox OP 104128755 : yes it is, Target price for this is 27. for long term.
I only play with small positions while I'm learning . I had 50 earlier sold 30 just alittle while ago. holding the other 20 just in case it keep rising if I don't get a dip to reenter
104128755 Rhiox OP : at such low shares, i think you should look into call options!
Rhiox OP 104128755 : I'm not experienced with those yet.
right now, I'm just practicing my day and swing trades , working on reaching a certain percentage to take profit on a steady basis.
104128755 Rhiox OP :
thats true, i made 4 k trading 0dTE options today, the margin of profit is definitely much higher but the risk is also much higher!
View more comments...